- Title
- ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa, a novel engineered cytokine, in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (326)
- Creators
- Thomas HerzogKathleen MoorePanagiotis KonstantinopoulosLucy GilbertJohn HaysBradley MonkDavid O’MalleyJalid SehouliJulie GrahamMonali DesaiYan WangYangchun DuLei SunRita DalalRobert Coleman
- Publication Details
- Gynecologic oncology, Vol.166, p.S169
- Identifiers
- 991005968782602656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa, a novel engineered cytokine, in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (326)
Gynecologic oncology, Vol.166, p.S169
08/2022
Metrics
7 Record Views